**Question:** The drug of choice for absence seizure

**Core Concept:** Absence seizure is a type of epilepsy characterized by brief, recurrent, and transient episodes of loss of consciousness with preserved autonomic function and no motor activity. The goal of treatment is to control seizures without causing significant side effects.

**Why the Correct Answer is Right:**

The correct answer is **B. Valproic acid (VPA)**, also known as valproic sodium or divalproex sodium. Valproic acid is a broad-spectrum antiepileptic drug (AED) that works by inhibiting the gamma-aminobutyric acid (GABA) transaminase enzyme, leading to increased levels of GABA (an inhibitory neurotransmitter) and prevention of seizure initiation and propagation. Valproic acid is considered the first-choice AED for absence seizures due to its high efficacy, low risk of adverse effects, and minimal effect on cognitive function.

**Why Each Wrong Option is Incorrect:**

A. **Levetiracetam (LEV)** is another AED, but it primarily acts by enhancing the synaptic release of GABA and is less effective in controlling absence seizures compared to VPA.
C. **Lamotrigine (LTG)** is an AED used for partial seizures but is less efficacious for generalized seizures, including absence seizures.
D. **Levetiracetam (LEV)** is less effective for generalized seizures and has higher risk of adverse effects compared to VPA.

**Clinical Pearl:**

In clinical practice, VPA is a preferred choice over other AEDs for absence seizures due to its proven efficacy, minimal cognitive impact, and better tolerability profile. It is essential to individualize treatment based on patient factors, seizure type, and potential drug interactions or contraindications.